Optimi Health Corp.
OPTHF
$0.1168
-$0.0052-4.26%
| Weiss Ratings | OPTHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | OPTHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | OPTHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.34 | |||
| Price History | OPTHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -12.84% | |||
| 30-Day Total Return | -20.44% | |||
| 60-Day Total Return | -28.95% | |||
| 90-Day Total Return | -27.90% | |||
| Year to Date Total Return | -27.90% | |||
| 1-Year Total Return | -37.34% | |||
| 2-Year Total Return | -34.82% | |||
| 3-Year Total Return | -57.22% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -69.50% | |||
| 52-Week Low % Change | 6.18% | |||
| Price | OPTHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.38 | |||
| 52-Week Low Price | $0.11 | |||
| 52-Week Low Price (Date) | Mar 07, 2025 | |||
| 52-Week High Price (Date) | Jun 03, 2024 | |||
| Valuation | OPTHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 11.06M | |||
| Enterprise Value | 12.94M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.05 | |||
| Earnings Per Share Growth | 14.52% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 40.28 | |||
| Price/Book (Q) | 1.56 | |||
| Enterprise Value/Revenue (TTM) | 47.63 | |||
| Price | $0.12 | |||
| Enterprise Value/EBITDA (TTM) | -4.38 | |||
| Enterprise Value/EBIT | -3.63 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | OPTHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 92.61M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | OPTHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 778 761 4551 | |||
| Address | 40440 Thunderbird Ridge Garibaldi Highlands, BC V0N 1T0 | |||
| Website | www.optimihealth.ca | |||
| Country | Canada | |||
| Year Founded | 2020 | |||
| Profitability | OPTHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1,313.91% | |||
| Profit Margin | -1,632.71% | |||
| Management Effectiveness | OPTHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -19.43% | |||
| Return on Equity | -- | |||
| Income Statement | OPTHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 271.70K | |||
| Total Revenue (TTM) | 271.70K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -47.50K | |||
| EBITDA (TTM) | -2.95M | |||
| EBIT (TTM) | -3.57M | |||
| Net Income (TTM) | -4.44M | |||
| Net Income Avl. to Common (TTM) | -4.44M | |||
| Total Revenue Growth (Q YOY) | 184.56% | |||
| Earnings Growth (Q YOY) | -27.99% | |||
| EPS Diluted (TTM) | -0.05 | |||
| EPS Diluted Growth (Q YOY) | -44.68% | |||
| Balance Sheet | OPTHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 76.70K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 912.40K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 7.09M | |||
| Current Ratio (Q) | 0.383 | |||
| Book Value Per Share (Q) | $0.07 | |||
| Total Assets (Q) | 10.77M | |||
| Total Current Liabilities (Q) | 2.38M | |||
| Total Debt (Q) | 2.04M | |||
| Total Liabilities (Q) | 3.68M | |||
| Total Common Equity (Q) | 7.09M | |||
| Cash Flow | OPTHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -113.30K | |||
| Cash from Financing (TTM) | 2.35M | |||
| Net Change in Cash (TTM) | -913.40K | |||
| Levered Free Cash Flow (TTM) | -1.22M | |||
| Cash from Operations (TTM) | -3.15M | |||
